E

Emcure Pharmaceuticals Ltd
NSE:EMCURE

Watchlist Manager
Emcure Pharmaceuticals Ltd
NSE:EMCURE
Watchlist
Price: 1 333.45 INR -5.15% Market Closed
Market Cap: 252.2B INR
Have any thoughts about
Emcure Pharmaceuticals Ltd?
Write Note

Wall Street
Price Targets

EMCURE Price Targets Summary
Emcure Pharmaceuticals Ltd

Wall Street analysts forecast EMCURE stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for EMCURE is 1 606.5 INR with a low forecast of 1 484.7 INR and a high forecast of 1 737.75 INR.

Lowest
Price Target
1 484.7 INR
11% Upside
Average
Price Target
1 606.5 INR
20% Upside
Highest
Price Target
1 737.75 INR
30% Upside
Emcure Pharmaceuticals Ltd Competitors:
Price Targets
DERM
Journey Medical Corp
79% Upside
SUPRIYA
Supriya Lifescience Ltd
15% Downside
AHEALTH
Apex Healthcare Bhd
14% Upside
600557
Jiangsu Kanion Pharmaceutical Co Ltd
68% Upside
GLAND
Gland Pharma Ltd
6% Upside
MANKIND
Mankind Pharma Ltd
4% Downside
GLENMARK
Glenmark Pharmaceuticals Ltd
3% Upside
DHG
Dhg Pharmaceutical Joint-Stock Co
5% Upside

Revenue
Forecast

Revenue Estimate
Emcure Pharmaceuticals Ltd

For the last 1 year the compound annual growth rate for Emcure Pharmaceuticals Ltd's revenue is 11%. The projected CAGR for the next 3 years is 14%.

11%
Past Growth
14%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Emcure Pharmaceuticals Ltd

For the last 1 year the compound annual growth rate for Emcure Pharmaceuticals Ltd's operating income is 0%. The projected CAGR for the next 3 years is 23%.

0%
Past Growth
23%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Net Income
Forecast

Net Income Estimate
Emcure Pharmaceuticals Ltd

For the last 1 year the compound annual growth rate for Emcure Pharmaceuticals Ltd's net income is -6%. The projected CAGR for the next 3 years is 33%.

-6%
Past Growth
33%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is EMCURE's stock price target?
Price Target
1 606.5 INR

According to Wall Street analysts, the average 1-year price target for EMCURE is 1 606.5 INR with a low forecast of 1 484.7 INR and a high forecast of 1 737.75 INR.

What is Emcure Pharmaceuticals Ltd's Revenue forecast?
Projected CAGR
14%

For the last 1 year the compound annual growth rate for Emcure Pharmaceuticals Ltd's revenue is 11%. The projected CAGR for the next 3 years is 14%.

What is Emcure Pharmaceuticals Ltd's Operating Income forecast?
Projected CAGR
23%

For the last 1 year the compound annual growth rate for Emcure Pharmaceuticals Ltd's operating income is 0%. The projected CAGR for the next 3 years is 23%.

What is Emcure Pharmaceuticals Ltd's Net Income forecast?
Projected CAGR
33%

For the last 1 year the compound annual growth rate for Emcure Pharmaceuticals Ltd's net income is -6%. The projected CAGR for the next 3 years is 33%.

Back to Top